サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1428181

前臨床イメージングの世界市場レポート 2024

Preclinical Imaging Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
前臨床イメージングの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

前臨床イメージングの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.5%の年間複合成長率（CAGR）で44億2,000万米ドルに成長すると予想されます。今後の成長が期待されるのは、個別化医療の採用、分子イメージングの進歩、医薬品開発のアウトソーシングの増加、規制当局からの支援、慢性疾患の拡大によるものです。予測期間の注目すべき動向には、環境に優しいイメージング技術、技術の強化、研究開発活動の急増、コラボレーション、パートナーシップ、リアルタイムイメージングの出現が含まれます。

予想される慢性疾患の急増は、前臨床イメージング市場の成長の重要な推進力となる見込みです。 3か月以上続く長期にわたる健康状態を特徴とする慢性疾患は、継続的な医学的管理を必要とし、個人の生活の質に大きな影響を与える可能性があります。 前臨床イメージングツールは、骨の構造と肺機能を視覚化することで、これらの疾患を特定する上で重要な役割を果たします。さらに、慢性疾患の研究にも貢献し、疾患の進行を視覚化し、全体的な理解を高めることができます。たとえば、2022年9月の世界保健機関（WHO）の2022年ハイライトのデータによると、世界の死亡の74%は非感染性疾患（NCD）または慢性疾患が原因であり、年間死亡者数は4,100万人に達します。注目すべきことに、これには心血管疾患による1,790万人、がんによる930万人、慢性呼吸器疾患による410万人、糖尿病による200万人が含まれています。したがって、慢性疾患の有病率の増加は、前臨床イメージング市場の成長の原動力となっています。

医薬品の需要の高まりにより、前臨床イメージング市場の拡大が促進されると考えられます。病状の予防、診断、または治療を目的として配合された物質を含む医薬品は、製薬業界において前臨床イメージングから大きな恩恵を受けます。この画像技術は、臨床試験に進む前に薬の有効性、安全性、作用機序についての貴重な洞察を提供することで意思決定を強化します。たとえば、ユーロスタットは2023年4月、医薬品および製薬品の輸出が2022年に前年比22%増加し、3,070億米ドル（2,870億ユーロ）に増加したと報告しました。同時に、医薬品輸入は2021年の1,070億米ドル（1,000億ユーロ）から2022年には1,200億米ドル（1,120億ユーロ）に増加しました。さらに、ドイツに本拠を置く製薬会社メルクグループは、2023年2月に、医薬品の売上高が2021年に増加したと報告しました。 2022年の売上高は593億米ドルに達し、2021年通年と比べて22%増加しました。その結果、医薬品に対する需要の高まりが前臨床イメージング市場の成長の主な原動力として浮上しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の前臨床イメージング市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の前臨床イメージング市場規模実績と成長、2018～2023年
  • 世界の前臨床イメージング市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の前臨床イメージング市場、モダリティ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 光学イメージングシステム
  • 前臨床核イメージングシステム
  • 微小磁気共鳴イメージングシステム
  • マイクロ超音波システム
  • マイクロコンピュータ断層撮影システム
  • 前臨床光音響イメージングシステム
  • 前臨床磁性粒子イメージング（MPI）システム
  • 世界の前臨床イメージング市場、試薬別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 前臨床光学イメージング試薬
  • 前臨床核イメージング試薬
  • 前臨床MRI造影剤
  • 前臨床超音波造影剤
  • 前臨床CT造影剤
  • 世界の前臨床イメージング市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 診断センター
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の前臨床イメージング市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の前臨床イメージング市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 前臨床イメージング市場の競合情勢
  • 前臨床イメージング市場の企業プロファイル
    • Thermo Fisher Scientific Inc.
    • FUJIFILM Visualsonics Inc.
    • Konica Minolta Inc.
    • Agilent Technologies Inc.
    • PerkinElmer Inc.

第31章 その他の大手および革新的な企業

  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Miltenyi Biotech
  • Sofie Biosciences Inc.
  • Promega Corporation
  • Ion Beam Applications SA
  • Nihon Kohden
  • EKF Diagnostics Holdings plc.
  • Piramal Enterprises Ltd
  • LI-COR Biosciences Inc.
  • Aspect Imaging Ltd
  • Capintec Inc.
  • Spectral Instruments Inc.
  • Mediso Ltd
  • MR Solutions Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14025

Preclinical imaging encompasses the utilization of various techniques to observe and analyze biological processes within animal models, preceding their application in human clinical trials. These imaging methods enable researchers to monitor disease progression, assess the effectiveness and safety of potential treatments, and acquire deeper insights into the underlying biological mechanisms of diseases.

Key modalities employed in preclinical imaging include optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems involve technologies that leverage light to visualize and capture images of biological tissues, cells, or molecules. They are utilized during the preclinical stage for research purposes, disease diagnosis, monitoring tumor blood vessel growth, and tracking tissue blood oxygenation in animals. This encompasses a spectrum of reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. Hospitals, diagnostic centers, and other entities form the primary user base for these technologies.

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides preclinical imaging market statistics, including preclinical imaging industry global market size, regional shares, competitors with a preclinical imaging market share, detailed preclinical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. This preclinical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be accredited to governmental initiatives, the rise in disease prevalence, expanding applications, heightened awareness, and the expansion of emerging markets.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. Anticipated growth in the upcoming period is attributable to the adoption of personalized medicine, advancements in molecular imaging, increased outsourcing of drug development, support from regulatory bodies, and the escalation of chronic diseases. Notable trends in the forecast period encompass eco-friendly imaging technologies, technological enhancements, an upsurge in research and development activities, collaborations, partnerships, and the emergence of real-time imaging.

The anticipated surge in chronic diseases is poised to be a significant driver of growth in the preclinical imaging market. Chronic diseases, characterized by prolonged health conditions lasting three months or more, necessitate ongoing medical management and can substantially impact individuals' quality of life. Preclinical imaging tools play a crucial role in identifying these diseases by visualizing bone structure and lung function. Moreover, they contribute to studying chronic diseases, enabling the visualization of disease progression and enhancing overall understanding. For instance, data from the World Health Organization (WHO) 2022 Highlights in September 2022 revealed that 74% of global deaths are caused by Noncommunicable diseases (NCDs) or chronic diseases, amounting to 41 million deaths annually. Notably, this includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is a driving force behind the growth of the preclinical imaging market.

The growing demand for pharmaceutical products is set to propel the expansion of the preclinical imaging market. Pharmaceutical products, encompassing substances formulated to prevent, diagnose, or treat medical conditions, benefit significantly from preclinical imaging in the pharmaceutical industry. This imaging technology enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before progressing to clinical trials. For instance, Eurostat reported in April 2023 that exports of medicinal and pharmaceutical products increased to $307 billion (€287 billion) in 2022, reflecting a 22% rise from the previous year. Concurrently, pharmaceutical product imports increased from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, the Merck Group, a Germany-based pharmaceutical company, reported in February 2023 that pharmaceutical product sales for the year 2022 reached $59.3 billion, marking a 22% increase over the full year 2021. Consequently, the heightened demand for pharmaceutical products emerges as a key driver for the growth of the preclinical imaging market.

Product innovation stands out as a prominent trend gaining traction in the preclinical imaging market, with major companies actively engaged in developing cutting-edge products to maintain their market positions. A notable example is Fujifilm VisualSonics Inc., a Canada-based biomedical company specializing in imaging systems, which introduced Vevo F2 for preclinical imaging in May 2022. Distinguished as the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system, Vevo F2 incorporates HD image processing technology and a novel signal pathway. These features contribute to enhanced image clarity, improved frame rates, and customization options tailored to precision imaging demands. With a broad scope of anatomical targets and high-resolution imaging capabilities, Vevo F2 is well-suited for diverse research applications.

Major players in the preclinical imaging market are intensifying their focus on introducing next-generation imaging systems, positioning themselves strategically to gain a competitive advantage. Next-generation imaging systems represent advanced technologies that surpass current capabilities, integrating cutting-edge features. In a significant development, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems in September 2023, aimed at driving innovation in various preclinical research applications. The product lineup includes the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system seamlessly integrating 2D optical and full 3D imaging. These imaging systems boast enhanced image-based capabilities and are designed to streamline the imaging workflow, marking a significant stride in advancing preclinical imaging technologies.

In August 2021, Rigaku Corporation, a Japanese company specializing in X-ray technology, completed the acquisition of MILabs B.V. The deal's financial details remained undisclosed. This strategic move by Rigaku Corporation is targeted at broadening its footprint within the life sciences sector. The acquisition is poised to reinforce the company's research and development capacities concerning its product range while leveraging MILabs' technological advancements and specialized knowledge. MILabs B.V., based in the Netherlands, is known for producing preclinical imaging systems catering to universities, biomedical research, and pharmaceutical studies.

Major companies operating in the preclinical imaging market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preclinical Imaging Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preclinical imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
  • 2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
  • 3) By End User: Hospital; Diagnostics Center; Other End-User
  • Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Visualsonics Inc.; Konica Minolta Inc.; Agilent Technologies Inc.; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preclinical Imaging Market Characteristics

3. Preclinical Imaging Market Trends And Strategies

4. Preclinical Imaging Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Preclinical Imaging Market Size and Growth

  • 5.1. Global Preclinical Imaging Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Preclinical Imaging Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Preclinical Imaging Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Preclinical Imaging Market Segmentation

  • 6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Optical Imaging Systems
  • Preclinical Nuclear Imaging Systems
  • Micro-magnetic Resonance Imaging Systems
  • Micro-Ultrasound Systems
  • Micro-computed Tomography Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems
  • 6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical Optical Imaging Reagents
  • Preclinical Nuclear Imaging Reagents
  • Preclinical MRI Contrast Agents
  • Preclinical Ultrasound Contrast Agents
  • Preclinical CT Contrast Agents
  • 6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostics Center
  • Other End-User

7. Preclinical Imaging Market Regional And Country Analysis

  • 7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Preclinical Imaging Market

  • 8.1. Asia-Pacific Preclinical Imaging Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Preclinical Imaging Market

  • 9.1. China Preclinical Imaging Market Overview
  • 9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Preclinical Imaging Market

  • 10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Preclinical Imaging Market

  • 11.1. Japan Preclinical Imaging Market Overview
  • 11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Preclinical Imaging Market

  • 12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Preclinical Imaging Market

  • 13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Preclinical Imaging Market

  • 14.1. South Korea Preclinical Imaging Market Overview
  • 14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Preclinical Imaging Market

  • 15.1. Western Europe Preclinical Imaging Market Overview
  • 15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Preclinical Imaging Market

  • 16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Preclinical Imaging Market

  • 17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Preclinical Imaging Market

  • 18.1. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Preclinical Imaging Market

  • 19.1. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Preclinical Imaging Market

  • 20.1. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Preclinical Imaging Market

  • 21.1. Eastern Europe Preclinical Imaging Market Overview
  • 21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Preclinical Imaging Market

  • 22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Preclinical Imaging Market

  • 23.1. North America Preclinical Imaging Market Overview
  • 23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Preclinical Imaging Market

  • 24.1. USA Preclinical Imaging Market Overview
  • 24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Preclinical Imaging Market

  • 25.1. Canada Preclinical Imaging Market Overview
  • 25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Preclinical Imaging Market

  • 26.1. South America Preclinical Imaging Market Overview
  • 26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Preclinical Imaging Market

  • 27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Preclinical Imaging Market

  • 28.1. Middle East Preclinical Imaging Market Overview
  • 28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Preclinical Imaging Market

  • 29.1. Africa Preclinical Imaging Market Overview
  • 29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Preclinical Imaging Market Competitive Landscape And Company Profiles

  • 30.1. Preclinical Imaging Market Competitive Landscape
  • 30.2. Preclinical Imaging Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. FUJIFILM Visualsonics Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Konica Minolta Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PerkinElmer Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Preclinical Imaging Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Bruker Corporation
  • 31.3. Miltenyi Biotech
  • 31.4. Sofie Biosciences Inc.
  • 31.5. Promega Corporation
  • 31.6. Ion Beam Applications S.A
  • 31.7. Nihon Kohden
  • 31.8. EKF Diagnostics Holdings plc.
  • 31.9. Piramal Enterprises Ltd
  • 31.10. LI-COR Biosciences Inc.
  • 31.11. Aspect Imaging Ltd
  • 31.12. Capintec Inc.
  • 31.13. Spectral Instruments Inc.
  • 31.14. Mediso Ltd
  • 31.15. MR Solutions Ltd

32. Global Preclinical Imaging Market Competitive Benchmarking

33. Global Preclinical Imaging Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Preclinical Imaging Market

35. Preclinical Imaging Market Future Outlook and Potential Analysis

  • 35.1 Preclinical Imaging Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Preclinical Imaging Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Preclinical Imaging Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer